Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SATIR: Simulect Versus ATG Fresenius in Sensitized Renal Transplant
NCT02377193Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2013
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of basiliximab in renal transplant rejection (RTR), sponsored by Centre hospitalier universitaire de Toulouse. Started Sep 2013; status: completed.
02
Drugs
basiliximab
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT02377193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02377193.